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a b s t r a c t
Objective: The objective of this study was to perform a landscape analysis of apoptosis-
related genes/proteins and to study the differential gene expression by analysing array data
from periodontitis patients and, second, to evaluate the anti-apoptotic effects of carvacrol, a
monoterpenoid phenol, in vitro.
Design: A gene/protein interaction network model ‘APOP’ was developed by using the
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) version 9.05. Differ-
ential gene expression was determined by using the limma package from R and false
discovery rate (FDR). With ViaComplex software, gene expression was plotted over the
network. The anti-apoptotic effect of carvacrol was tested on sorbitol-treated HaCaT cells,
by using a commercial kit for caspase-3 activity.
Results: The ‘APOP’ model characterised the landscape of interactions between apoptosis-
related genes/proteins in silico. Forty-nine out of 70 genes from this model, such as CSF2RB,
NFKBIE, ENDOG, CASP10 and CASP3, were differentially expressed (corrected p-value < 0.05)
in periodontitis samples when compared to those of healthy controls. In addition, carvacrol
(0.43%) was able to inhibit the pro-apoptotic effects induced by sorbitol (0.3 M), as seen by
the reduction in caspase-3 activity on HaCaT cells.
Conclusion: Our results suggest that caspase-3 can be a target protein to inhibit period-
ontitis-associated apoptosis of epithelial cells and that carvacrol has therapeutic potential
as an anti-apoptotic agent.
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Bioinformatics has established itself as an essential tool in
science and the in silico analysis of gene expression/function
has become an integral part of it by guiding the researchers
towards the selection of the most relevant targets in the
context of any disease.1 Our group has successfully applied
these tools in different areas of research such as pharmacog-
nosy, neuroscience and toxicology.2–4
Periodontitis is an infection-induced chronic inflammatory
disease of tooth-supporting tissues. Destruction initiates from
the soft tissues (epithelium and gingival connective tissue)
and continues to the hard tissues (alveolar bone) of the
periodontium. Different bacteria, such as Aggregatibacter
actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas
gingivalis, Prevotella intermedia, Tannerella forsythia and Trepo-
nema denticola, have been associated with both the initiation
and regulation of soft and hard tissue destruction during
periodontal inflammation.5 In periodontal tissues, the balance
between cell death and survival of resident cells, provided by
physiological programmed cell death (e.g., autophagy and
apoptosis), is critical for tissue homeostasis.6 Autophagy is
considered a self-degradative process, critical for the balance
of energy sources at specific times as it removes aggregated
proteins and/or damaged organelles as well as eliminates
intracellular pathogens.7 For instance, mitochondria play an
important role in pro-inflammatory signalling and generation
of reactive oxygen species (ROS), and it is regarded as an
important activator of inflammasome-mediated inflamma-
tion.8 Thus, the turnover of non-functional mitochondria (or
mitophagy) would become essential in inflammatory scenar-
ios, such as periodontitis, in order to maintain tissue home-
ostasis. As a matter of fact, increased levels of autophagy gene
expression and high levels of mitochondrial ROS production in
peripheral blood mononuclear cells from patients with
periodontitis have already been reported.9 Pathogenic bacteria
induce several changes in resident cells of the gingiva
(epithelial cells and fibroblasts), including the stimulation of
cytokines and production of antimicrobial peptides, modula-
tion of matrix metalloproteinase (MMP) secretion and induc-
tion of apoptosis.10–12 Periodontitis-associated bacteria induce
apoptosis in different ways: A. actinomycetemcomitans induces
apoptosis in a caspase-3-dependent manner,13 P. gingivalis
initiates anti-apoptotic mechanisms in early infection and
stimulates pro-apoptotic mechanisms in continuing infec-
tion14 and F. nucleatum triggers apoptosis in epithelial cells by
inducing caspase-3 expression; however, such an effect seems
to be strain-dependent.15
Inhibition of tissue destruction is one of the main goals in
host modulation therapies for periodontal inflammation by
suppressing bacterial challenge and regulating tissue
response.16 Essential oils (EOs) have been proposed as natural
therapeutic agents due to their antibacterial and anti-
gelatinolytic properties.2 Satureja hortensis L. EO, with carvacrol
as its main active component, has been shown to exhibit
strong antibacterial effects on periodontopathogenic bacteria
and to decrease their cytotoxicity and excessive MMP
production by epithelial cells in vitro.17,18 In fact, in our recent
study, it was demonstrated that 0.05% of S. hortensis L. EO isable to inhibit cell death and increase the proliferation of
human epithelial cells.18 These events could be a result of anti-
apoptotic properties induced by S. hortensis L. EO. In the
present continuation study, we hypothesised that its anti-
apoptotic effect depends on carvacrol, which is the main
compound of S. hortensis L. EO. Our aims were (1) to
characterise the apoptotic landscape in periodontitis with
an in silico approach and a pathway-focussed (apoptosis)
microarray analysis and (2) to analyse the effect of carvacrol as
an anti-apoptotic agent in vitro.
2. Materials and methods
2.1. Network development
The apoptosis interaction network model ‘APOP’ was devel-
oped by associating a total of 70 apoptosis-related genes/
proteins (Table 1), provided by the Kyoto Encyclopedia of
Genes and Genomes (KEGG) PATHWAY database (http://
www.genome.jp/kegg/pathway.html; Apoptosis: map04210).
The network was generated by using the database resource
search tool Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) version 9.05 (http://string-db.org/) for the
retrieval of interacting genes19 with ‘Experiments’ and
‘Databases’ as input options and a confidence score of 0.400.
STRING is a well-known public database with information
about direct and indirect functional protein–protein interac-
tions. The genes/proteins belonging to the ‘APOP’ model were
identified by the Human Genome Organisation (HUGO) Gene
Symbol20 and Ensemble protein ID. Once they were selected,
the links between two different nodes (genes/proteins) were
provided by the STRING database and saved in data files to be
handled in the Medusa interface.21
2.2. Differential gene expression analysis
Microarray data were downloaded from the international
repository (Gene Expression Omnibus, http://www.ncbi.nlm.-
nih.gov/geo/; GEO accession No.: GSE10334; Platform: GPL570,
Affymetrix), an experiment that is composed of 247 human
samples (64 healthy and 183 diseased gingival samples).22 In
order to perform the differential gene expression analysis,
normalised data of periodontitis samples versus controls were
analysed by using the limma package from R and false
discovery rate (FDR)23,24 for statistical assessment of the
microarray data (corrected p-values < 0.05 were considered
significant). The means of gene expression in diseased
samples were plotted versus the expression found in healthy
ones to be visualised with ViaComplex.25 This software plots
gene expression over the Medusa network (in a colour scale) by
overlapping functional input data (microarray expression
data) with interaction information (‘APOP’ model) and
distributes the microarray signal according to the coordinates
of the nodes and its interactions in the network of interest.
2.3. Chemicals and concentrations
Carvacrol (282197) was purchased from Sigma. For every test
performed on epithelial cells, a concentration of carvacrol of
Table 1 – Differentially expressed genes (down or up-regulated) from the interaction network model ‘‘APOP’’ (periodontitis
vs. healthy samples).
Gene symbol Ensemble
protein ID
Gene name/description Differential
gene
expression
Corrected
p-value < 0.05
CSF2RB ENSP00000384053 Colony stimulating factor 2 receptor, beta, low-affinity
(granulocyte–macrophage)
UP 4.99976E16
NFKBIE ENSP00000275015 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, epsilon
UP 3.52219E12
ENDOG ENSP00000361725 Endonuclease G DOWN 1.11789E11
CASP10 ENSP00000286186 Caspase 10 UP 5.29366E11
CASP3 ENSP00000311032 Caspase 3 UP 2.84703E10
BID ENSP00000318822 BH3 interacting domain death agonist UP 3.88191E10
CFLAR ENSP00000312455 CASP8 and FADD-like apoptosis regulator UP 1.94246E09
IL1B ENSP00000263341 Interleukin 1, beta UP 5.23217E09
ATM ENSP00000278616 Ataxia telangiectasia mutated UP 3.03187E08
BCL2 ENSP00000329623 B-cell CLL/lymphoma 2 UP 6.78125E08
PAWR ENSP00000328088 PRKC, apoptosis, WT1, regulator DOWN 9.79553E08
PPP3CC ENSP00000240139 Protein phosphatase 3, catalytic subunit, gamma isozyme UP 1.80816E07
IRAK3 ENSP00000261233 Interleukin-1 receptor-associated kinase 3 UP 3.67862E07
BIRC3 ENSP00000263464 Baculoviral IAP repeat containing 3 UP 5.88785E07
CASP8 ENSP00000351273 Caspase 8 UP 7.1311E07
BCL2L1 ENSP00000302564 BCL2-like 1 UP 9.79044E07
CASP9 ENSP00000330237 Caspase 9 UP 2.3836E06
BAX ENSP00000293288 BCL2-associated X protein UP 3.658E06
IL1A ENSP00000263339 Interleukin 1, alpha UP 4.48708E06
MYD88 ENSP00000379625 Myeloid differentiation primary response gene (88) DOWN 6.81905E06
TNFSF10 ENSP00000241261 Tumour necrosis factor (ligand) superfamily, member 10 UP 7.55029E06
DFFA ENSP00000366237 DNA fragmentation factor, 45 kDa, alpha polypeptide UP 1.11559E05
MAP3K14 ENSP00000342059 Mitogen-activated protein kinase kinase kinase 14 UP 0.000101503
NFKB2 ENSP00000189444 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells 2 (p49/p100)
UP 0.000103961
CASP6 ENSP00000265164 Caspase 6 DOWN 0.00010583
IRAK1 ENSP00000358997 Interleukin-1 receptor-associated kinase 1 UP 0.000595167
FASLG ENSP00000356694 Fas ligand (TNF superfamily, member 6) UP 0.000847119
APAF1 ENSP00000353059 Apoptotic peptidase activating factor 1 UP 0.001268061
IKBKG ENSP00000358622 Inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase gamma
UP 0.001300281
BAD ENSP00000309103 BCL2-associated agonist of cell death UP 0.002391555
TNFRSF10A ENSP00000221132 Tumour necrosis factor receptor superfamily, member 10a DOWN 0.002593051
NFKBIZ ENSP00000325663 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, zeta
UP 0.002864101
PPP3CB ENSP00000378306 Protein phosphatase 3, catalytic subunit, beta isozyme UP 0.003828891
CIDEA ENSP00000339344 Cell death-inducing DFFA-like effector a DOWN 0.005352422
FAS ENSP00000347979 Fas (TNF receptor superfamily, member 6) DOWN 0.005897434
TRADD ENSP00000341268 TNFRSF1A-associated via death domain UP 0.006002501
TNFRSF10B ENSP00000276431 Tumour necrosis factor receptor superfamily, member 10b UP 0.007023252
TNF ENSP00000392858 Tumour necrosis factor UP 0.007409663
CASP7 ENSP00000298700 Caspase 7 UP 0.014457117
IL1R1 ENSP00000233946 Interleukin 1 receptor, type I UP 0.015435312
IRAK2 ENSP00000256458 Interleukin-1 receptor-associated kinase 2 UP 0.016514545
CHUK ENSP00000359424 Conserved helix-loop-helix ubiquitous kinase DOWN 0.018964518
PRKCA ENSP00000284384 Protein kinase C, alpha UP 0.019393692
RELA ENSP00000384273 v-rel reticuloendotheliosis viral oncogene homolog A
(avian)
UP 0.025020711
DFFB ENSP00000367454 DNA fragmentation factor, 40 kDa, beta polypeptide (cas-
pase-activated DNase)
UP 0.025975985
NFKB1 ENSP00000226574 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells 1
UP 0.027024066
IRAK4 ENSP00000349096 Interleukin-1 receptor-associated kinase 4 DOWN 0.027895001
IL3RA ENSP00000327890 Interleukin 3 receptor, alpha (low affinity) UP 0.028674832
TRAF2 ENSP00000247668 TNF receptor-associated factor 2 UP 0.030407183
NFKBIB ENSP00000312988 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, beta
No 0.053288736
PPP3R1 ENSP00000234310 Protein phosphatase 3, regulatory subunit B, alpha No 0.055729615
AKT1 ENSP00000270202 v-akt murine thymoma viral oncogene homolog 1 No 0.075569289
AIFM1 ENSP00000287295 Apoptosis-inducing factor, mitochondrion-associated, 1 No 0.090967934
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Table 1 (Continued )
Gene symbol Ensemble
protein ID
Gene name/description Differential
gene
expression
Corrected
p-value < 0.05
BIRC2 ENSP00000227758 Baculoviral IAP repeat containing 2 No 0.099538022
PPP3CA ENSP00000378323 Protein phosphatase 3, catalytic subunit, alpha isozyme No 0.105342754
NTRK1 ENSP00000351486 Neurotrophic tyrosine kinase, receptor, type 1 No 0.108543576
NFKBIL2 ENSP00000386239 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor-like 2
No 0.109150906
CAPN2 ENSP00000295006 Calpain 2 (m/II) large subunit No 0.131183193
IL3 ENSP00000296870 Interleukin 3 (colony-stimulating factor, multiple) No 0.138840006
IKBKB ENSP00000339151 Inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase beta
No 0.14825754
CAPN1 ENSP00000279247 Calpain 1 (mu/I) large subunit No 0.171100789
NGF ENSP00000358525 Nerve growth factor (beta polypeptide) No 0.171317423
CIDEB ENSP00000258807 Cell death-inducing DFFA-like effector b No 0.191423981
RIPK1 ENSP00000259808 Receptor (TNFRSF)-interacting serine-threonine kinase 1 No 0.302440791
TP53 ENSP00000269305 Tumour protein p53 No 0.539824907
IL1RAP ENSP00000072516 Interleukin 1 receptor accessory protein No 0.613518474
FADD ENSP00000301838 Fas (TNFRSF6)-associated via death domain No 0.709388393
PPP3R2 ENSP00000363939 Protein phosphatase 3, regulatory subunit B, beta No 0.822298246
TNFRSF1A ENSP00000162749 Tumour necrosis factor receptor superfamily, member 1A No 0.872878353
NFKBIA ENSP00000216797 Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
No 0.996703605
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composition of S. hortensis L. EO and the concentration in
which S. hortensis L. EO (5 ml ml1 or 0.5%, v/v) prevented cell
death in the presence of a pro-oxidant insult and stimulated
the proliferation of epithelial cells, as shown in our previous
study.18 As the tested EO contained 86% of carvacrol in its
composition, only 0.43% of carvacrol was then used in this
continuation study. In addition, a higher concentration of
carvacrol (4.3%) was used for the antibacterial experiments, as
only 5% of S. hortensis L. EO was shown to display an
antibacterial effect against periodontopathogens.18
2.4. Cell culture
Human epithelial keratinocytes (HaCaT cells) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) containing foetal
calf serum (10%), l-glutamine (1%) and penicillin G (1%) in an
atmosphere of 5% CO2 at 37 8C.
2.5. Bacterial culture
The utilised bacterial strains (Table 2) came from the culture
collection of anaerobic bacteria of the National Institute for
Health and Welfare (THL). All bacteria were grown on brucella
blood agar enriched with hemin and incubated at 37 8C in an
anaerobic chamber for 5 days.
2.6. Caspase-3 activity
HaCaT cells were incubated overnight in 96-well plates to 80%
confluency. Cells were pretreated with either 4.3 ml ml1
(0.43%) of carvacrol or just DMEM for control cells for
10 min at 37 8C in a CO2 incubator. Afterwards, the tests
groups were incubated with sorbitol (0.3 M)26 for 1 h. Then,
caspase-3 activity was analysed according to the manufac-
turer’s instructions provided in the kit (CASP3F; Sigma).2.7. Antibacterial activity
Antibacterial activity of carvacrol against the selected bacter-
ial strains was determined by a disc diffusion assay with slight
modifications.18 Briefly, one 5-day-old colony from the first
passage of each bacterial strain was inoculated on brucella
blood agar. Discs of 6 mm diameter were impregnated in 15 ml
of carvacrol at the tested concentration (4.3%) and then placed
onto the inoculated agar plates, which were incubated at 37 8C
in an anaerobic chamber for 5 days. Five micrograms of
metronidazole (nitroimidazole antibiotic) was used as a
positive control for antibacterial effect. The solvent, dimethyl
sulphoxide (DMSO), was used as a negative control. There-
after, the inhibition zone was measured and the effect
calculated. All the tests were done in triplicates (independent
experiments).
2.8. Statistical analysis
Differences between the test and control groups (in vitro
experiments) were analysed by using the Student’s t-test.
Results were considered significant (*) with a p-value < 0.05.
3. Results
3.1. The in silico network model ‘APOP’ and its
differentially expressed genes characterise apoptosis in
periodontitis
In order to perform a focussed DNA microarray analysis of
apoptosis in periodontitis samples, the network model ‘APOP’,
composed of 70 genes (Table 1) involved in apoptotic process,
was developed (Fig. 1A; for further details, see Section 2). These
apoptosis-related genes were submitted to further analysis
with the ViaComplex software, which plots the expression
Fig. 1 – Interaction network model of apoptosis-related genes developed by using the STRING 9.05 database resource search
tool, under a confidence score of 0.400 (A). Gene expression of diseased gingival samples vs. healthy controls plotted over
the network model ‘‘APOP’’ (B). The Z-axis was constructed with ViaComplex software for 2D (B.1) and 3D (B.2) view
representation of gene expression.
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the expression of healthy ones (Z-axis) in the network model
‘APOP’, presenting them as two- and three-dimensional (2D and
3D) ViaComplex-generated landscapes (Fig. 1B and C). Analysis
of differential gene expression showed that a total of 49 out of 70genes belonging to the network model were differentially
expressed (corrected p-value < 0.05) in periodontitis samples in
comparison to healthy controls. CSF2RB, NFKBIE, ENDOG,
CASP10, CASP3, BID, CFLAR, IL1B, ATM and BCL2 were the most
differentially expressed genes (Table 1).
Fig. 2 – Effect of carvacrol against sorbitol-induced caspase-
3 activity on HaCaT cells. Differences between treated and
control cells were considered significant (*) when p-
value < 0.05.
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in epithelial cells
After treating epithelial cells with 0.3 M of sorbitol for 1 h,
there was a significant increase in caspase-3 activity
( p-value < 0.05) when compared to control cells (Fig. 2).
Sorbitol-induced caspase-3 activation was prevented when
cells were pretreated with carvacrol (0.43%) for 10 min
( p-value < 0.05; Fig. 2).
3.3. Modest antibacterial activity of carvacrol against
periodontopathogenic strains when compared to
metronidazole
Carvacrol (4.3%) displayed a modest antibacterial activity
against the tested periodontopathogens (Table 2) except for a
strain of P. gingivalis (AHN 24135), when compared to our
positive control (metronidazole). Metronidazole was stronglyTable 2 – Antibacterial effects of carvacrol against periodontitis
inhibition zone <1 mm; + modest antimicrobial activity, inhib
inhibition zone: 5–10 mm; +++, strong antimicrobial activity, i
Bacterial strain 
Aggregatibacter actinomycetemcomitans AHN 24195 
NTCC 9710 
Fusobacterium nucleatum AHN 9508 
ATCC 25586 
Parvimonas micra AHC 15107 
AHC 15154 
ATCC 33270 
Porphyromonas gingivalis AHN 24135 
AHN 24155 
ATCC 33277 
Prevotella intermedia AHN 8290 
ATCC 25611 
Prevotella nigrescens AHN 8293 
ATCC 33563 effective against the examined bacterial strains except for A.
actinomycetemcomitans (AHN 24195 and NTCC 9710), F. nucle-
atum (AHN 9508) and P. gingivalis (AHN 24135). DMSO (a
negative control) did not show any antibacterial effect.
4. Discussion
In the present study, we characterised the landscape of
interactions of apoptosis-related genes/proteins by construct-
ing an in silico network model where 70% of these genes were
differentially expressed in periodontitis patients. In addition,
we showed in vitro evidence for the anti-apoptotic properties
of carvacrol on epithelial cells and its antibacterial effect
against a number of periodontopathogens. To the best of our
knowledge, this is the first study reporting that carvacrol is
able to inhibit caspase-3 activity in human epithelial cells
when challenged with sorbitol. The use of one single
concentration of carvacrol for the in vitro experiments could
be seen as a weakness in the present report. However, it has to
be clearly remarked that this set of experiments represents a
continuation study from our recently published work, where
we showed that 0.5% of S. hortensis L. EO did not trigger
cytotoxicity and prevented oxidative stress-induced epithelial
cell death.18 Therefore, in the present report, we tested
whether the amount of carvacrol found in such a concentra-
tion of EO (0.43% carvacrol) could additionally exert anti-
apoptotic properties in vitro. To achieve this goal, we
challenged human epithelial cells with sorbitol (0.3 M)26which
is a well-known inducer of apoptosis, mediated by oxidative/
nitrosative stress rather than a canonical hyperosmotic
shock,27 and checked the potential anti-apoptotic capabilities
of carvacrol in vitro by measuring caspase-3 activity. According
to our results, 0.43% carvacrol was able to prevent the sorbitol-
induced increase of caspase-3 activity in human epithelial
cells (Fig. 2). Both caspase expression and activation are
connected by various apoptotic signalling systems. Caspases
are synthesised as inactive precursors (pro-caspases) and are-associated bacteria. Symbols: S, no antimicrobial activity,
ition zone: 2–4 mm; ++, clear antimicrobial activity,
nhibition zone >10 mm.
Metronidazole (5 mg)
(positive control)
Carvacrol
(43 ml ml1)
 +
 +
 +++
+++ ++
+++ +
+++ +
+++ +
 
+++ +
+++ +
+++ ++
+++ +
+++ ++
+++ +
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activation of pro-caspases result in an amplified proteolytic
cascade reaction. Therefore, it should be remembered that the
activity of caspases does not necessarily relate with its
expression. Carvacrol-induced inhibition of apoptosis is likely
due to its reported antioxidant properties in vitro.29 This is
consistent with another report where carvacrol attenuated the
impairment caused by acute myocardial infarction of rats, and
these beneficial effects were also attributed to its antioxidative
potential.30
In periodontitis, epithelial cells form the first barrier
against invasion and periodontitis-associated bacteria, such
as A. actinomycetemcomitans, are able to invade epithelial cells
by stealth without triggering inflammation through the
induction of apoptosis.31 These bacteria possess the ability
of promoting apoptosis in macrophages which could be
important also for the initiation of infection and the devel-
opment of periodontitis.32 Moreover, A. actinomycetemcomitans,
after 24 h of exposure, is able to induce the overexpression of
genes involved in tissue remodelling and bone resorption (e.g.,
CSF2), genes encoding components of the low-density lipo-
protein (LDL) pathway, as well as nuclear factor-kB-dependent
genes and cytokines in gingival epithelial cells.33 In addition,
A. actinomycetemcomitans has been reported to produce
leucotoxin that selectively lyses primate neutrophils and
monocytes, that is, major populations of defence cells in the
periodontium, and their lysis by such a toxin seems to depend
on caspase-1 activation.34 Despite these reports, the question
is whether apoptosis could be considered a generalised
pathological process present in periodontal inflammation.
Our pathway-focussed microarray analysis revealed that the
majority of genes (49 out of the 70 genes) belonging to our
network model were differentially expressed (up- or down-
regulated) in patients with periodontitis (Fig. 1 and Table 1),
suggesting that apoptosis could be, in general terms, an
important biological event in this pathogenic context. These
results are consistent with other studies performed at the
clinical level. For instance, Makhoul et al., who examined the
putative link between apoptotic biomarkers in gingival
crevicular fluid and periodontal destruction in four cases of
localised aggressive periodontitis, found a significant increase
in the apoptotic markers Fas/FasL together with DNA
fragmentation when comparing gingival crevicular fluid from
diseased versus non-diseased sites in patients.35 Furthermore,
periodontitis is well recognised as one of the main complica-
tions of diabetes mellitus.36 Recently, it was demonstrated
that high glucose levels induces concentration- and caspase-
3-dependent increase of apoptosis in cultured human period-
ontal ligament fibroblasts, whereas inhibitors of caspase-3 can
prevent the high-glucose-induced apoptosis in these cells.37
Apoptosis is also a critical process for the resolution of
inflammation as it is the mechanism by which neutrophil
lifespan is regulated.38 These cells are polymorphonuclear
leucocytes and represent the host’s first line of defence against
bacterial and fungal infections, but their overactivity can
cause tissue damage and prolong the extent and severity of
inflammatory periodontal diseases. Neutrophil death by
apoptosis together with a safe removal (of intact apoptotic
neutrophils) by phagocytic cells (macrophages) contribute to
limit tissue damage during the resolution of an inflammatoryresponse.38,39 The mechanisms by which neutrophil apoptosis
is activated/inactivated are still under intense investigation
but it seems to be clear, for instance, that a number of growth
factors and cytokines, such as interleukin (IL)-1 beta, IL-2, IL-
15, tumour necrosis factor-a, interferon-g, BCL2, granulocyte
colony-stimulating factor, granulocyte–macrophage colony-
stimulating factor (CSF2) and lipopolysaccharides, are known
to prolong the survival of these cells and impede neutrophil
apoptosis, impairing the resolution of inflammation.38,40,41 In
our array analysis, CSF2RB, IL1B and BCL2 are among the top
ten up-regulated genes in periodontitis samples (Table 1),
suggesting that neutrophil numbers within the present
diseased tissues could be extremely high. By contrast, the
caspase-cascade system plays critical roles in the induction,
transduction and amplification of intracellular apoptotic
signals.42 Considering that both CASP3 and CASP10 were also
highly up-regulated in periodontitis patients (Table 1), we
speculate that both increases may be indicative of apoptosis of
other cellular compartments than neutrophils, such as
epithelial cells. Besides, our array analysis defines the
apoptotic changes at the tissue level, without taking the
cellular type into account, as the analysed samples come from
healthy and diseased gingival tissues.22 In the best-case
scenario, any potential drug aimed to be used for the
treatment of periodontal inflammation should protect
epithelial cells against apoptosis in a pro-oxidant environ-
ment without inhibiting the constitutive neutrophil death
(essential for modulating neutrophil homeostasis), display an
analgesic effect and show antibacterial properties against
common periodontopathogens. Interestingly enough, it has
been already demonstrated that pre-treatment with carva-
crol is able to significantly attenuate the number of
neutrophils and exert anti-nociceptive activity in vivo.43,44
Our data now show evidence of anti-apoptotic properties of
carvacrol in human epithelial cells when challenged with
sorbitol (Fig. 2). Thus, the last question to be addressed was
whether carvacrol exerts any antibacterial activity against
periodontitis-associated pathogens. Our group described the
antibacterial effect of S. hortensis L. EO against periodontitis-
associated bacteria and its anti-gelatinolytic properties
against PMA-induced MMP activity of human epithelial
cells.18 As this EO from S. hortensis L. contained 86% of
carvacrol, its potential antibacterial properties were further
tested against the same periodontal bacterial strains. In
general, a modest antibacterial effect was seen against all
tested bacteria, except for one strain of P. gingivalis (AHN
24135), by the disc diffusion assay. This strain was also
resistant to 5 mg of metronidazole, which was used as our
positive control (Table 2). Moreover, neither A. actinomyce-
temcomitans (AHN 24195 and NTCC 9710) nor F. nucleatum (AHN
9502) was sensitive to metronidazole. Such a discrepancy can
be explained by the fact that the resistance or susceptibility of
periodontal bacteria against metronidazole is strain depen-
dent.45 One final point to address is that, in the present study,
anti-apoptotic effects of carvacrol were tested on a non-
tumorigenic HaCaT keratinocyte cell line. HaCaT cells have
been widely used in studies on host–bacteria interactions and
our group has demonstrated infection-related responses of
this same cell line (i.e., proliferation, cell death, IL-8 and beta-
defensin secretion) against periodontal pathogens.46–49
a r c h i v e s o f o r a l b i o l o g y 5 9 ( 2 0 1 4 ) 4 6 1 – 4 6 9468To the best of our knowledge, this is the first study showing
a focussed microarray analysis of apoptosis-related genes in
the context of periodontal inflammation. Several genes
involved in this biological process are deregulated in period-
ontitis. Anti-apoptotic properties of carvacrol, displayed in the
present study, refer to the need for further therapeutic
exploration of this compound.
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